Is Captoappetit™ safe?

Captoappetit™ contains a highly purified viscous polysaccharide obtained from selected, non GMO vegetal sources, associated in a well-defined proportion with a gas-adsorbing inert substance. It mechanically induces satiety feeling in the stomach and blocks the assimilation of nutrients from the foods present in the gastrointestinal lumen, without being absorbed and without interfering with cellular activities or having other effects on human body. In fact, CaptoappetitTM calms hunger and blocks the absorption of dietary fats and sugars without eliciting any pharmacological, immunological or metabolic action or effects on the human body. As a result of this non-systemic mechanism of action, products made with Captoappetit™ are certified as a Class IIa medical device* under the Medical Device Directive 93/42/EEC. All the studies conducted also confirm the safety profile of Captoappetit™. No adverse reactions were observed. Any batch is thoroughly controlled for its content of active principle and the absence of contaminants, and totally traceable. The production of Captoappetit™ is made in compliance with the strictest Good Manufacturing Practices. The formulation and the excipients used are gluten-free. The brand Captoappetit™ is a registered trademark of SIIT.
The brand Captoappetit™ is a registered trademark of SIIT.

What is a Medical Device?

A medical device is defined as any article, whether used alone or in combination, intended by the manufacturer to be used for human beings for the purpose of: prevention, monitoring, treatment or alleviation of disease and which achieves its principal intended action in or on the human body, not through any pharmacological, immunological or metabolic means, but which may be assisted in its function by such means.

The effectiveness of Captoappetit™ is confirmed by the results of laboratory and clinical studies